Friday, April 19, 2019 7:43:03 AM
To my mind, here's the difference: a scientist seeking to determine which cannabinoids can cure ailments by extracting compounds, running them through trials... and then developing medicine based off of results... vs. a scientist knowing what cannabinoids he needs for his medicine, and using an engineered plant that contains a boatload of them for extraction...
Which scenario works best in terms of efficiency and effectiveness? This ship hasn't sailed... little faith is required to fill the evidence gap... some of the evidence we have is our (past?) relationship with Anandia prior to them being bought out by ACB... we are a plant biotech co. ...let's see if KeyGene can amplify our portfolio... in any case- it's our backpocket
Our endgame is BT
Recent XXII News
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/01/2024 09:15:52 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/25/2024 09:15:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2024 10:05:22 AM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 10/23/2024 11:27:00 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 10/15/2024 09:20:35 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/15/2024 01:09:49 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/10/2024 09:43:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2024 01:07:12 PM
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 10/09/2024 01:58:17 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 10/08/2024 11:23:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/08/2024 12:00:18 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 10/04/2024 08:53:44 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/01/2024 01:20:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/30/2024 01:15:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/30/2024 10:44:03 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/25/2024 09:00:31 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 09/16/2024 10:21:11 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 09/16/2024 09:26:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2024 05:31:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 01:14:57 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 09/05/2024 08:17:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/28/2024 01:00:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2024 01:00:13 PM
- Form 253G3 - • Edgar (US Regulatory) • 08/16/2024 09:27:31 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM